Next year is an election year. There is little chance of a big tax increase, or a government shutdown or debt crisis.» Read More
**FACEBOOK INC, Wednesday close $45.04, up 1 pct premarket. Shares of Facebook rose more than 3 percent to a new high on Wednesday, valuing the world's No. 1 social network at $106 billion, as investors focused on its recent mobile advertising advances and the potential to expand ad revenue into new areas.
**ARCH COAL INC, Wednesday close $5.11. **ALPHA NATURAL RESOURCES INC, Wednesday close $6.65. **JAMES RIVER COAL CO, Wednesday close $2.30.
SHANGHAI, Sept 11- Chinese insulin maker Gan& Lee Pharmaceuticals said on Wednesday it was investigating allegations published in a newspaper that it spent around 800 million yuan to bribe doctors to promote the firm's drugs over five years.
**MOLEX INC, $38.54, up 31.4 pct. The maker of electronic connectors and cable assembly products said privately owned energy and chemicals conglomerate Koch Industries would buy it for about $7.2 billion. **MOSAIC CO, $43.69, up 3.6 pct.
**MOLEX INC, $38.47, up 31 pct. The maker of electronic connectors and cable assembly products said privately owned energy and chemicals conglomerate Koch Industries would buy it for about $7.2 billion. Shares of fertilizer companies jumped after Russian President Vladimir Putin said on Friday that it was necessary to resolve a potash dispute with Belarus.
U.S. stocks rose, helping the S&P advance for a fifth straight day following upbeat economic data from China, though concerns about the possibility of a Western strike against Syria tempered investor enthusiasm. **MOLEX INC, $38.47, up 31 pct.
U.S. stocks rose at the open in the wake of upbeat economic data from China, though concerns remained about the possibility of a Western strike against Syria and its impact on the global economy. **MOLEX INC, $38.47, up 31 pct.
U.S. stocks were set for a modestly higher open on Monday in the wake of upbeat economic data from China, though concerns remained about the possibility of a Western strike against Syria. **APPLE INC, Friday close $498.22, up 1.5 pct premarket.
*Market access is the top concern for European business in China. BEIJING, Sept 5- Foreign pharmaceutical firms in China have been unfairly targeted by a string of investigations into bribery and price-fixing despite generally strong legal compliance, a European Union business lobby said on Thursday.
Check out which companies are making headlines after the bell Wednesday:
As resources move to other areas, cardiologists fear the battle against heart disease could stall after advances marked by critical drugs to lower cholesterol and blood pressure.
Some of the names on the move ahead of the open.
European shares closed slightly lower on Monday with fears of a government collapse in Italy dragging down the FTSE MIB, and with U.K. markets closed for a holiday.
China's benchmark index shot up to a seven-week high on Monday, boosting Asian stocks across the board on optimism that the world's second-largest economy may be stabilizing, but Japan bucked the trend after weak growth data.
China has started investigating French drugmaker Sanofi for allegedly bribing more than 500 Chinese doctors with about 1.7 million yuan ($277,600) of payments to raise sales, China's Xinhua state news agency said on Saturday.
Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk, the latest evidence of a widening investigation into Western drugmakers.
WASHINGTON, July 29- Sanofi SA's allergy drug Nasacort AQ is safe enough to be used without a prescription, according to reviewers for the U.S. Food and Drug Administration. Sanofi hopes increased sales of non-prescription and consumer products will help compensate for the loss of sales from prescription products that over time lose patent protection.
July 25- Biogen Idec Inc on Thursday reported sales of its new multiple sclerosis drug Tecfidera had surpassed Wall Street's most bullish forecasts, raising expectations that it will eventually become the dominant oral MS treatment. Analysts had expected about $66 million, with the more bullish forecasts at about $90 million.
*Novartis to submit pricing information before final decision. ZURICH, July 24- Swiss drugmaker Novartis suffered a fresh blow to the turnaround prospects of its loss-making vaccines division as a key committee advised against including its meningitis B vaccine on Britain's routine vaccination programme.
NEW YORK/ LOS ANGELES, July 12- Swiss drugmaker Roche Holding AG is seeking financing for a potential bid for Alexion Pharmaceuticals Inc, a transaction that if successful would be the largest healthcare deal of the year, two people familiar with the matter said on Friday.